Your browser doesn't support javascript.
loading
Four-year outcome of aflibercept administration using a treat-and-extend regimen in eyes with recurrent neovascular age-related macular degeneration.
Tsunekawa, Yuma; Kataoka, Keiko; Asai, Keiko; Ito, Yasuki; Terasaki, Hiroko.
Afiliação
  • Tsunekawa Y; Department of Ophthalmology, Handa City Hospital, Handa, Japan.
  • Kataoka K; Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, 466-8550, Japan. kkeiko@med.nagoya-u.ac.jp.
  • Asai K; Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, 466-8550, Japan.
  • Ito Y; Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, 466-8550, Japan.
  • Terasaki H; Department of Ophthalmology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, 466-8550, Japan.
Jpn J Ophthalmol ; 65(1): 69-76, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33159611

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Degeneração Macular Exsudativa / Degeneração Macular Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Degeneração Macular Exsudativa / Degeneração Macular Idioma: En Ano de publicação: 2021 Tipo de documento: Article